Gleevec
| Gleevec | |
|---|---|
| Term | Gleevec |
| Short definition | Gleason score (GLEE sun. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Gleevec - (pronounced) (GLEE-vek) A drug used to treat certain types of leukemia and other blood cancers, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma protuberans, and a rare condition called systemic mastocytosis. It is also being studied in the treatment of other diseases and cancers. Gleevec blocks certain proteins made by the BCR-ABL, PDGFR, or c-KITO oncogene, which can help prevent cancer cells from growing and kill them. Gleevec is a type of tyrosine kinase inhibitor. Also called imatinib mesylate and STI571
External links
- Medical encyclopedia article on Gleevec
- Wikipedia's article - Gleevec
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski